50906-56-4
Chemical Structure
Arteannuin B
- CAS No.: 50906-56-4
- Formula:C15H20O3
- Molecular Weight:248.32
IUPAC Name: (1aR,1bR,4aS,7R,7aS,9aR)-7,9a-dimethyl-4-methylenedecahydro-3H-oxireno[2',3':7,8]naphtho[8a,1-b]furan-3-one
InChIKey: QWQSMEDUZQDVLA-KPHNHPKPSA-N
SMILES: C[C@@]1(CC[C@]2([H])[C@@]3(OC4=O)[C@](CC[C@H]2C)([H])C4=C)[C@H]3O1
Biological Activity: Arteannuin B, No. 2000 can be jointly submitted with the blue material. Arteannuin B had anti-SARS-CoV-2 activity, EC50=10.28 μM[1][2][3].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Arteannuin B | 99.89% | Arteannuin B, No. 2000 can be jointly submitted with the blue material. Arteannuin B had anti-SARS-CoV-2 activity, EC50=10.28 μM. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Arteannuin B (Standard) | ≥98% | Arteannuin B, No. 2000 can be jointly submitted with the blue material. Arteannuin B had anti-SARS-CoV-2 activity, EC50=10.28 μM. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
-
Similarity Score 0.70
HY-N9395Dihydroarteannuin B -
Similarity Score 0.61
HY-N17729Michelenolide -
Similarity Score 0.58
HY-129117Arteannuin L -
Similarity Score 0.58
HY-N0141Parthenolide -
Similarity Score 0.57
HY-N2899Arteannuin M -
Similarity Score 0.56
HY-N1012(-)-11,13-Dehydroeriolin -
Similarity Score 0.56
HY-N13905Alliacol A -
Similarity Score 0.54
HY-N17252-Desoxy-4-epi-pulchellin -
Similarity Score 0.54
HY-N3840Epoxyparvinolide -
Explore the MedChemAI to find more analogs
References
- [1]. Ruiyuan Cao, et al. Anti-SARS-CoV-2 Potential of Artemisinins In Vitro. RETURN TO JUST ACCEPTED MANUSCRIPTS.
- [2]. Nair MS, et al. Bioconversion of arteannuin B to artemisinin. J Nat Prod. 1993 Sep;56(9):1559-66. [Content Brief]
- [3]. Varela K, et al. Inhibition of Cysteine Proteases via Thiol-Michael Addition Explains the Anti-SARS-CoV-2 and Bioactive Properties of Arteannuin B. J Nat Prod. 2023 Jul 28;86(7):1654-1666. [Content Brief]